Impact of the First Generation of Children’s Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor

Autor:	Jeffrey S. Dome, Murali Chintagumpala, David Dix, Peter F. Ehrlich, Elizabeth Perlman, James I. Geller, Paul E. Grundy, Lindsay A. Renfro, Najat C. Daw, Eric J. Gratias, Geetika Khanna, John A. Kalapurakal, Conrad V. Fernandez, Elizabeth Mullen
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Lung Neoplasms medicine.medical_treatment Wilms Tumor Article Cog Internal medicine medicine Humans Child Survival rate Chemotherapy Lung business.industry Wilms' tumor medicine.disease Kidney Neoplasms Progression-Free Survival Survival Rate Clinical trial Radiation therapy medicine.anatomical_structure Toxicity business
Zdroj:	J Natl Compr Canc Netw
ISSN:	1540-1413 1540-1405
DOI:	10.6004/jnccn.2021.7070
Popis:	Refinements in surgery, radiation therapy, and chemotherapy since the mid-20th century have resulted in a survival rate exceeding 90% for patients with Wilms tumor (WT). Although this figure is remarkable, a significant proportion of patients continue to have event-free survival (EFS) estimates of
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf06d1877991255c5cee28f5cbc72c18 https://doi.org/10.6004/jnccn.2021.7070 Zobrazit plný text záznamu